RecruitingNot ApplicableNCT06190665

DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC

DEB-TACE With Visualable Microspheres Versus PVA Microspheres for Hepatocellular Carcinoma: a Prospective, Multicenter, Randomized Controlled, Non-inferior Trial


Sponsor

Zhongda Hospital

Enrollment

188 participants

Start Date

Dec 19, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate the safety and efficacy of DEB-TACE with visualable embolization microspheres versus PVA microspheres for hepatocellular carcinoma.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of tiny beads used during a liver artery procedure (called TACE) to treat liver cancer — one type is visible on imaging (DEB with visualable microspheres) versus standard beads — to see which works better. **You may be eligible if...** - You have liver cancer (hepatocellular carcinoma) that requires the TACE procedure - You are not a candidate for surgery, liver transplant, or ablation, or you have declined those options - Your liver function is classified as Child-Pugh A or B (reasonably preserved) - Your general health score (ECOG) is 0–2 - You have at least one measurable tumor that has not yet been treated with TACE **You may NOT be eligible if...** - Your liver cancer has spread outside the liver - Your liver function is severely impaired (Child-Pugh C) - Your kidney function is severely impaired - You have a complete blockage of the main portal vein by tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDEB-TACE with visualable microspheres

Drug-eluting Beads Transcatheter Arterial Chemoembolization(DEB-TACE) with visualable microspheres

DEVICEDEB-TACE with PVA microspheres

Drug-eluting Beads Transcatheter Arterial Chemoembolization(DEB-TACE) with polyvinyl alcohol microspheres


Locations(2)

Peking University First Hospital

Beijing, Beijing Municipality, China

Zhongda Hospital,Southeast University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06190665


Related Trials